Stock comparison
JOHNSON & JOHNSON is 4.9x more valuable than VERTEX PHARMACEUTICALS INC / MA by market capitalization ($623.71 B vs $126.01 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
JNJ is larger
JOHNSON & JOHNSON is 4.9x more valuable than VERTEX PHARMACEUTICALS INC / MA by market capitalization ($623.71 B vs $126.01 B).
Market value leader
JNJ
JOHNSON & JOHNSON is 4.9x more valuable than VERTEX PHARMACEUTICALS INC / MA by market capitalization ($623.71 B vs $126.01 B).
Revenue leader
JNJ
VRTX: $12.00B vs JNJ: $94.19B.
Profit leader
JNJ
VRTX: $3.95B vs JNJ: $26.80B.
Margin leader
VRTX
VRTX: 32.9% vs JNJ: 28.5% net margin.
| Metric | VRTX | JNJ |
|---|---|---|
| Market cap | $126.01 B | $623.71 B |
| US-listed rank | #123 | #17 |
| Revenue (latest FY) | $12.00B | $94.19B |
| Net income (latest FY) | $3.95B | $26.80B |
| Net margin | 32.9% | 28.5% |
| P/E (trailing FY) | 31.9x | 23.3x |
| SEC filings | 1,000 | 990 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
JOHNSON & JOHNSON is 4.9x more valuable than VERTEX PHARMACEUTICALS INC / MA by market capitalization ($623.71 B vs $126.01 B).
In their latest fiscal years, VERTEX PHARMACEUTICALS INC / MA reported $12.00B in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: VERTEX PHARMACEUTICALS INC / MA and JOHNSON & JOHNSON, or browse the full rankings.